A Study of SHR6508 in Secondary Hyperparathyroidism
Clinical trial NCT05663411 · UNKNOWN
Trial details
- NCT number
- NCT05663411
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-24
- Primary completion
- 2023-10-31
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.